Trials / Completed
CompletedNCT00622375
PK Study of Encapsulated Mesalamine Granules in Healthy Volunteers
A Phase I, Single- And Multiple-Dose, Relative Bioavailability and Pharmacokinetic Study of Encapsulated Mesalamine Granules Administered Orally to Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The current study is being conducted to evaluate the relative bioavailability and single- and multiple-dose pharmacokinetics of encapsulated mesalamine granules(eMG) in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mesalamine | encapsulated mesalamine granules |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2008-02-01
- Completion
- 2008-05-01
- First posted
- 2008-02-25
- Last updated
- 2019-11-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00622375. Inclusion in this directory is not an endorsement.